Blood bank reagents

Ended Awarded

Contract number
36C25520N0289
Awardee
Awarding agency
Obligated
$7,472

Award facts

Contract value 22% obligated
  • $7,472.17 Current, with exercised options
  • $33,623.65 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Emeryville, CA 94608, USA

Award details come from SAM.gov/FPDS.

About this award

This is a federal contract awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit subsidiary of the global healthcare company Grifols. The $33,623.65 firm-fixed-price contract is for the provision of blood bank reagents through a Blanket Purchase Agreement (BPA) call under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits & Test Sets. The contract supports the VA's Integrated Service Network 15 and does not have a set-aside designation. Grifols, a major supplier of plasma-derived medicines, transfusion medicine products, and laboratory equipment to the federal government, has received over $8 million in prior awards from agencies like the VA, Department of Defense, and Defense Logistics Agency for similar medical supplies and services. This contract facilitates the ongoing procurement of Grifols' proprietary blood bank testing systems and reagents by VA medical facilities across the country.

Quick answers

Who was awarded contract 36C25520N0289?

36C25520N0289 was awarded to Grifols Diagnostic Solutions Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 1, 2020.

How much is contract 36C25520N0289 worth?

The government has obligated $7,472 on 36C25520N0289. Its potential value, with all options, is $33,624.

Is contract 36C25520N0289 an order under another contract?

Yes. 36C25520N0289 is a BPA call under 36F79720D0083-36C25520A0037, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C25520N0289 competed?

The extent of competition for 36C25520N0289 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award